Description: Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company's principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees. Its products also include Altura endovascular stent graft system for the treatment of standard AAA anatomies; Aorflex delivery system for accurate placement of Aorfix in the abdominal aorta; and IntelliFlex LP delivery system that enhances the precision and control of Aorfix deployment and placement. Lombard Medical, Inc. sells its products directly through its direct sales force and distributors to state-or-government-owned hospitals. The company was founded in 2000 and is headquartered in Didcot, the United Kingdom.
Home Page: www.lombardmedical.com
4 Trident Park
Didcot,
OX11 7HJ
United Kingdom
Phone:
44 12 3575 0800
Officers
| Name | Title |
|---|---|
| Mr. Kurt B. Lemvigh | Chief Exec. Officer |
| Dr. Peter Phillips | Chief Technology Officer |
| Andrew Debbage | VP of Operations |
| Mr. Jonathan Hornsby | VP of Sales & Marketing |
| Ms. Kate Forster | VP of HR |
| Paul Hardwick | VP of Sales |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.0218 |
| IPO Date: | 2005-12-13 |
| Fiscal Year End: | December |
| Full Time Employees: | 113 |